Status:
COMPLETED
Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Antimicrobial Resistance
Eligibility:
All Genders
18+ years
Brief Summary
International travel is well reported to be associated with acquisition of multidrug-resistant organisms, however, the impact of colonization of these multidrug-resistant organisms is currently uncert...
Eligibility Criteria
Inclusion
- Adults aged 18 years or above
- Chinese ethnicity
- Planning to visit any places outside of Hong Kong within the next three months
- Able to provide informed consent
Exclusion
- Use of antibiotics within 4 weeks prior to the time of recruitment (Except for antimalarial prophylaxis)
- Hospitalization within 3 months
- Underlying gastrointestinal diseases, including gastrointestinal malignancy, inflammatory bowel disease, resection of small or large bowel
- Pregnancy
Key Trial Info
Start Date :
November 5 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2023
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT03794479
Start Date
November 5 2018
End Date
June 6 2023
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong